Avita is still burning cash and the road to profitability depends on clinical readouts for further indications over the next few years, with the use of RECELL currently limited to adult and paediatric ...

Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001to treat uveitic ...

TransDigm operates as a private-equity-like public company, so its capital allocation is meaningfully different than most aerospace and defense companies we cover. TransDigm maintains a significant ...

Good day and welcome to Adaptive Biotechnologies third quarter financial results. (Operator Instructions) As a reminder, this call may be recorded. I would like to turn the call over to Karina ...

Q3 2024 Earnings Call Transcript November 6, 2024 UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.82. Operator: Good morning, ladies and gentlemen. Thank ...

This opportunity creates ... and Medicaid lines of business for a regional health plan in the Eastern great Lakes region.

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET. Company Participants. Matthew Kreps - Investor Relations Jeffrey Soinski - Chief Executiv ...

we anticipate meaningfully growing this area of our business as we showcase the strategic benefits of tal and government partners including other branches as well as our allies overseas to spearhead ...

The global physiotherapy equipment market is projected to reach USD 27.03 billion by 2029 from USD 20.13 billion in 2024, at a CAGR of ...

Operator: Good day, and welcome to the Third Quarter 2024 Pacira Biosciences Inc. Earnings Conference Call. At this time, all ...